[1] Ahlstedt S, Olaisson E, Thelin J, et al. Appearance of mast cells in bone marrow, peripheral blood and spleen of immunized rats[J]. Int Arch Allergy Appl Immunol, 1986,80(2):122-126.[2] Hume D A, Ross I L, Himes S R, et al. The mononuclear phagocytes system revisited[J]. J Leukoc Biol, 2002,72(4):621-627.[3] Sánchez-Martin L, Estecha A, Samaniego R, et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression[J]. Blood, 2011,117(1):88-97.[4] Hotamisligil G S. Inflammation and metabolic disorders[J]. Nature, 2006,444(7121):860-867.[5] Gordon S. Alternative activation of macrophages[J]. Nat Rev Immunol, 2003,3(1):23-35.[6] Murray P J, Wynn T A. Protective and pathogenic functions of macrophage subsets[J]. Nat Rev Immunol, 2011,11(11):723-737.[7] Wynn T A, Barron L. Macrophages: master regulators of inflammation and fibrosis[J]. Semin Liver Dis, 2010,30(3):245-257.[8] Hansson G K, Hermansson A. The immune system in atherosclerosis[J]. Nat Immunol, 2011,12(3):204-212.[9] Libby P, Ridker P M, Hansson G K. Progress and challenges in translating the biology of atherosclerosis[J]. Nature, 2011, 473(7347):317-325.[10] Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas[J]. J Clin Invest, 2012,122(3):787-795.[11] 穆珺,庄晓明,刘锐敏,等.血清巨噬细胞移动抑制因子、肿瘤坏子因子-α与糖尿病肾病的相关性研究[J].首都医科大学学报,2012,33(3):385-388.[12] 章必成,高建飞.M2型巨噬细胞:肿瘤治疗的新靶点[J].临床误诊误治,2012,25(4):64-66. |